Pyrophyte Acquisition Corp. II SEC filings PAII
Pyrophyte Acquisition Corp. II has 35 filings in SEC EDGAR's recent list, going back to May 29, 2025. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Current report | Oct 15, 2026 | — |
| EFFECT | Filing | Jul 16, 2025 | — |
| CERT | Nyse certification | Jul 16, 2025 | — |
| 8-A12B | For registration of certain classes | Jul 16, 2025 | — |
| CORRESP | Letter to the SEC | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 14, 2025 | — |
| CORRESP | Letter to the SEC | Jul 14, 2025 | — |
| CORRESP | Letter to the SEC | Jul 11, 2025 | — |
| CORRESP | Letter to the SEC | Jul 11, 2025 | — |
| DRS | Filing | May 29, 2025 | — |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- PAII (NYSE), PAII-UN (NYSE), PAII-WT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Houston, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2069238
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.